the Effect of Exercise and Oral Supplement Intervention in Sarcopenia Markers in Hemodialysis Patients

Sponsor
China Medical University Hospital (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05809219
Collaborator
(none)
200
4
10

Study Details

Study Description

Brief Summary

Objective: To assess the effect of different post-exercise oral nutritional supplement intake timing on sarcopenia indicators in hemodialysis patients.

Study Design: 24-weeks Randomized Control Trial (RCT), includes 12-wk intervention period and 12-week follow up period.

Setting & Participants: Maintenance hemodialysis patients who were older than 20 years old meet sarcopenia diagnosis criteria.

Intervention: Group A: During intervention period, participants have 3 times exercise program per week. Each program is 30 minutes of resistance exercise and aerobic exercise.

Participants take oral supplement in 1 to 2 hours after exercise program. Group B:

Participants have the same exercise program and oral supplement as Group A. However, they take oral supplement in 2.5-4 hours after exercise program. Group C: Participants only take oral supplement. Control group: Participants maintain usual diet and physical activity without any intervention.

Condition or Disease Intervention/Treatment Phase
  • Other: 1 hour combined intervention ( Exercise and nutrition)
  • Other: 3 hours combined intervention ( Exercise and nutrition)
  • Dietary Supplement: Nutrition intervention
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
200 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
The Effect of Different Post-exercise Oral Nutritional Supplement Intake Timing on Sarcopenia Indicators in Hemodialysis Patients
Anticipated Study Start Date :
May 1, 2023
Anticipated Primary Completion Date :
Feb 29, 2024
Anticipated Study Completion Date :
Feb 29, 2024

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Control group

Participants maintain usual diet and physical activity without any intervention

Experimental: 1 hour combined intervention ( Exercise and nutrition)

During intervention period, participants have 3 times exercise program per week. Each program is 30 minutes of resistance exercise and aerobic exercise. Participants take oral supplement (103 kcal and 8.4 g of protein) in 1 to 2 hours after exercise program.

Other: 1 hour combined intervention ( Exercise and nutrition)
Subjects take oral supplement after exercise in the time period between 1-2 hours. They will take oral supplement during hemodialysis treatment.

Experimental: 3 hours combined intervention ( Exercise and nutrition)

The only one different between "1 hour combined intervention" and this intervention is the time interval between exercise and nutrition. The time interval of "1 hour combined intervention" is 1 to 2 hour, and this intervention is 2.5-4 hours. Other procedure is totally the same.

Other: 3 hours combined intervention ( Exercise and nutrition)
All procedures between "1 hour combined intervention" and "3 hours combined intervention" are the same. The only one different is the time interval between exercise and nutrition. In this arm, the time interval of exercise and nutrition is 2.5 to 4 hours. When we recruiting subjects, all interventions will be clearly introduced to them, including the same and the different parts among them.

Experimental: Nutrition intervention

Participants only take oral supplement. The oral supplement is the same as the "1 hour combined intervention" and "3 hours combined intervention".

Dietary Supplement: Nutrition intervention
Subjects only take oral supplement during hemodialysis treatment. The oral supplement is the same as the "1 hour combined intervention" and "3 hours combined intervention".

Outcome Measures

Primary Outcome Measures

  1. Appendicular skeletal muscle mass [Change from baseline appendicular skeletal muscle mass at 3 months]

    The weight of appendicular skeletal muscle mass. This is one of the sarcopenia indicator.

  2. Appendicular skeletal muscle mass [Change from baseline appendicular skeletal muscle mass at 6 months]

    The weight of appendicular skeletal muscle mass. This is one of the sarcopenia indicator.

  3. Muscle strength [Change from baseline muscle strength at 3 months]

    The measurement of handgrip strength. This is one of the sarcopenia indicator.

  4. Muscle strength [Change from baseline muscle strength at 6 months]

    The measurement of handgrip strength. This is one of the sarcopenia indicator.

  5. Physical performance [Change from baseline physical performance at 3 months]

    Measuring whether the of 6-meter walk is less than 1.0 m/s or not. This is one of the sarcopenia indicator.

  6. Physical performance [Change from baseline physical performance at 6 months]

    Measuring whether the of 6-metre walk is less than 1.0 m/s or not. This is one of the sarcopenia indicator.

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Hemodialysis treatment longer than 3 months

  • Hemodialysis treatment 3 times treatment per weeks

  • Kt/V≥1.2 or URR≥65%

  • Taking foods by oral

  • Meeting the criteria of sarcopenia.

Exclusion Criteria:
  • Soy allergy

  • Amputation

  • Significantly edema

  • Receiving palliative care

  • Severe angina

  • Unstable arrhythmias

  • Severe infection

  • Heart failure (class 4 of New York Heart Association scale)

  • Central venous catheter or femoral arteriovenous fistula

  • Pacemaker

  • Pregnancy

  • Severe paleness

  • Severe difficulty breathing

  • Chest pain

  • Hospitalization 3 months before recruited in this study

  • Oral supplement intolerance diagnosed by the doctor or dietitian

  • Bone injury/nerve damage/cognition impairment affecting physical activity intervention

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • China Medical University Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Pei-Yu Wu, Project Assistant Professor, China Medical University Hospital
ClinicalTrials.gov Identifier:
NCT05809219
Other Study ID Numbers:
  • NSTC 112-2320-B-039-008
First Posted:
Apr 12, 2023
Last Update Posted:
Apr 14, 2023
Last Verified:
Apr 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 14, 2023